186 related articles for article (PubMed ID: 16683971)
1. Detection of non-adherent behaviour in early psychosis.
Hui CL; Chen EY; Kan CS; Yip KC; Law CW; Chiu CP
Aust N Z J Psychiatry; 2006 May; 40(5):446-51. PubMed ID: 16683971
[TBL] [Abstract][Full Text] [Related]
2. Anti-psychotics adherence among out-patients with schizophrenia in Hong Kong.
Hui CL; Chen EY; Kan C; Yip K; Law C; Chiu CP
Keio J Med; 2006 Mar; 55(1):9-14. PubMed ID: 16636644
[TBL] [Abstract][Full Text] [Related]
3. Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis.
Rabinovitch M; Béchard-Evans L; Schmitz N; Joober R; Malla A
Can J Psychiatry; 2009 Jan; 54(1):28-35. PubMed ID: 19175977
[TBL] [Abstract][Full Text] [Related]
4. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
5. A large-scale validation study of the Medication Adherence Rating Scale (MARS).
Fialko L; Garety PA; Kuipers E; Dunn G; Bebbington PE; Fowler D; Freeman D
Schizophr Res; 2008 Mar; 100(1-3):53-9. PubMed ID: 18083007
[TBL] [Abstract][Full Text] [Related]
6. Examining adherence to medication and substance use as possible confounds of duration of untreated psychosis.
Norman RM; Malla AK
J Nerv Ment Dis; 2002 May; 190(5):331-4. PubMed ID: 12011614
[No Abstract] [Full Text] [Related]
7. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
9. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
Byerly MJ; Nakonezny PA; Rush AJ
Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
[TBL] [Abstract][Full Text] [Related]
10. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia.
Byerly MJ; Thompson A; Carmody T; Bugno R; Erwin T; Kashner M; Rush AJ
Psychiatr Serv; 2007 Jun; 58(6):844-7. PubMed ID: 17535946
[TBL] [Abstract][Full Text] [Related]
11. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.
Piette JD; Heisler M; Ganoczy D; McCarthy JF; Valenstein M
Psychiatr Serv; 2007 Feb; 58(2):207-12. PubMed ID: 17287377
[TBL] [Abstract][Full Text] [Related]
12. Survey of medication adherence in patients with schizophrenia--Korean ADHES data.
Kim SW; Yoon JS; Choi SK
Hum Psychopharmacol; 2006 Dec; 21(8):533-7. PubMed ID: 17133616
[TBL] [Abstract][Full Text] [Related]
13. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis.
Hui CLM; Poon VWY; Ko WT; Miao HY; Chang WC; Lee EHM; Chan SKW; Lin J; Chen EYH
Schizophr Res; 2016 Jul; 174(1-3):144-149. PubMed ID: 27050476
[TBL] [Abstract][Full Text] [Related]
15. Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients' and clinicians' perspectives in a clinical trial.
Faries D; Ascher-Svanum H; Phillips G; Nyhuis AW; Sugihara T; Stauffer V; Kinon BJ
BMC Med Res Methodol; 2012 Sep; 12():142. PubMed ID: 22974273
[TBL] [Abstract][Full Text] [Related]
16. Emotional dysfunction in schizophrenia spectrum psychosis: the role of illness perceptions.
Watson PW; Garety PA; Weinman J; Dunn G; Bebbington PE; Fowler D; Freeman D; Kuipers E
Psychol Med; 2006 Jun; 36(6):761-70. PubMed ID: 16563207
[TBL] [Abstract][Full Text] [Related]
17. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
[TBL] [Abstract][Full Text] [Related]
18. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.
Nakonezny PA; Byerly MJ; Rush AJ
Psychiatry Res; 2008 Jan; 157(1-3):259-63. PubMed ID: 17935793
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia.
Eticha T; Teklu A; Ali D; Solomon G; Alemayehu A
PLoS One; 2015; 10(3):e0120560. PubMed ID: 25816353
[TBL] [Abstract][Full Text] [Related]
20. Non-adherence to antipsychotic medication in first-episode psychosis patients.
Hickling LM; Kouvaras S; Nterian Z; Perez-Iglesias R
Psychiatry Res; 2018 Jun; 264():151-154. PubMed ID: 29631247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
